期刊文献+

补肾中药辅助抗胸腺细胞球蛋白治疗急性再障疗效分析 被引量:1

下载PDF
导出
摘要 再生障碍性贫血(简称再障)是一组由理化、生物等多种原因所造成的骨髓造血干细胞缺陷、造血微环境损伤及免疫功能异常,进而导致骨髓造血功能衰竭、全血细胞减少综合征。急性再障(AAA)的发病率虽然低于慢性再障,但来势凶猛,进展迅速,病死率高,自然生存期短。
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2010年第7期768-770,共3页 Chinese Journal of Integrated Traditional and Western Medicine
  • 相关文献

参考文献7

  • 1Chen J, Lipovsky k, Ellison FM, et al. Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure [ J]. Blood, 2004, 104(6) :1671- 1678.
  • 2Rosenfeld S, Follmann D, Nunez O, et al. Antithymocyte globulin and cyclosporin for severe aplastic anemia: assoviation between hematologic response and long-term outcome [J].JAMA, 2003, 289(9):1130-1135.
  • 3Frickhofen N, Heimpel H, Kahwasser JP, et al. Antithymocyte globulin with or without cyclosporin A : 11-year follow-up of a randomized trial comparing treatments of aplastic anemia [ J ]. Blood, 2003, 101 (4) : 1236- 1242.
  • 4Schrezenmeier H, Marin P, Raghavaehar A, et al. Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party. [J]. Br J Haematol, 1993, 85(2): 371- 377.
  • 5Viollier R, Passweg J, Gregor M, et al. Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastie anemia [J]. Ann Hematol, 2005, 84(1):47-55.
  • 6Bacigalupo A, Hows J, Gluckman E, et al. Bone marrow transplantation (BMT) versus immunosuppression (IS) for the treatment of severe aplastic anemia (SAA) : a report of the EBMT SAA working party [J]. Br J Haematol, 1988, 70(2) : 177- 182.
  • 7Tiehelli A, Socie G, Henry-Amar M, et al. Effectiveness of immunosuppressive therapy in older patients with aplastic anemia [J]. Ann Intern Med, 1999, 130(3) :193-201.

同被引文献16

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部